BCRX SG&A Expense Growth
Biocryst Pharmaceuticals Inc · SG&A Expense Growth
BCRX SG&A Expense Growth
Latest reported31.01%period ending
BCRX FY SG&A Growth (YoY) (0.00% → 31.01%)
Latest values, visible window
High-resolution chart · PNG
BCRX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 31.0053% | |
| 24.4224% | |
| 34.2114% | |
| 34.1304% | |
| 74.915% | |
| 82.9935% | |
| 25.7742% | |
| 111.828% | |
| 23.8159% | |
| -13.7503% | |
| 74.8693% | |
| 42.931% | |
| -23.5277% | |
| -44.6481% | |
| -13.0263% | |
| 23.4997% | |
| 10.4024% | |
| 9.8592% | |
| 54.967% | |
| 65.7037% | |
| 14.7559% | |
| 14.236% | |
| -1.5339% | |
| -6.4312% | |
| -14.201% | |
| 22.664% | |
| -6.4516% | |
| 14.8148% | |
| 0% | |
| 22.7273% | |
| 15.7895% | |
| 0% |